Vienna Powszechne Towarzystwo Emerytalne S.A. Vienna Insurance Group Arvinas, Inc. Transaction History
Vienna Powszechne Towarzystwo Emerytalne S.A. Vienna Insurance Group
- $255 Billion
- Q2 2024
A detailed history of Vienna Powszechne Towarzystwo Emerytalne S.A. Vienna Insurance Group transactions in Arvinas, Inc. stock. As of the latest transaction made, Vienna Powszechne Towarzystwo Emerytalne S.A. Vienna Insurance Group holds 57,500 shares of ARVN stock, worth $1.45 Million. This represents 0.6% of its overall portfolio holdings.
Number of Shares
57,500
Previous 57,500
-0.0%
Holding current value
$1.45 Million
Previous $2.37 Billion
35.51%
% of portfolio
0.6%
Previous 0.93%
Shares
4 transactions
Others Institutions Holding ARVN
# of Institutions
224Shares Held
68.7MCall Options Held
166KPut Options Held
31.3K-
Eco R1 Capital, LLC San Francisco, CA6.73MShares$169 Million6.33% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.67MShares$168 Million0.0% of portfolio
-
Black Rock Inc. New York, NY6.26MShares$157 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.99MShares$100 Million0.01% of portfolio
-
Avidity Partners Management LP Dallas, TX2.99MShares$75.1 Million3.91% of portfolio
About ARVINAS, INC.
- Ticker ARVN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 53,205,300
- Market Cap $1.34B
- Description
- Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...